| 0 |
AVIAN INFLUENZA |
13 |
0.2031 |
| 1 |
HYPERGLYCAEMIC CRISIS |
9 |
0.1731 |
| 2 |
RENAL GRAFT INFECTION |
13 |
0.0560 |
| 3 |
PROBIOTIC THERAPY |
5 |
0.0505 |
| 4 |
PSEUDOPOLYP |
9 |
0.0250 |
| 5 |
DIABETIC GASTROPARESIS |
9 |
0.0245 |
| 6 |
URINARY TRACT INFECTION PSEUDOMONAL |
13 |
0.0216 |
| 7 |
ISCHAEMIC ENTERITIS |
2 |
0.0206 |
| 8 |
HEPATOBILIARY CANCER |
1 |
0.0167 |
| 9 |
CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION |
4 |
0.0134 |
| 10 |
ESCHERICHIA TEST POSITIVE |
9 |
0.0075 |
| 11 |
CLOSTRIDIUM TEST POSITIVE |
16 |
0.0072 |
| 12 |
CLOSTRIDIUM DIFFICILE INFECTION |
129 |
0.0059 |
| 13 |
ENTHESOPATHY |
9 |
0.0058 |
| 14 |
ROTAVIRUS INFECTION |
3 |
0.0052 |
| 15 |
ADENOVIRUS INFECTION |
13 |
0.0045 |
| 16 |
LASER THERAPY |
1 |
0.0044 |
| 17 |
PARENTERAL NUTRITION |
1 |
0.0043 |
| 18 |
CHRONIC DISEASE |
1 |
0.0039 |
| 19 |
CULTURE STOOL POSITIVE |
1 |
0.0036 |
| 20 |
ENTEROCOLITIS BACTERIAL |
1 |
0.0036 |
| 21 |
CLOSTRIDIUM COLITIS |
4 |
0.0033 |
| 22 |
ADENOCARCINOMA GASTRIC |
3 |
0.0032 |
| 23 |
ARRHYTHMIC STORM |
1 |
0.0030 |
| 24 |
GRAFT VERSUS HOST DISEASE IN LIVER |
2 |
0.0028 |
| 25 |
KLEBSIELLA INFECTION |
13 |
0.0026 |
| 26 |
ESCHERICHIA BACTERAEMIA |
6 |
0.0025 |
| 27 |
PSEUDOMONAL BACTERAEMIA |
2 |
0.0023 |
| 28 |
COLON NEOPLASM |
2 |
0.0021 |
| 29 |
CARDIAC VALVE VEGETATION |
1 |
0.0021 |
| 30 |
CLOSTRIDIUM DIFFICILE COLITIS |
21 |
0.0020 |
| 31 |
RESPIRATORY TRACT INFECTION FUNGAL |
1 |
0.0019 |
| 32 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
4 |
0.0019 |
| 33 |
COLECTOMY TOTAL |
1 |
0.0018 |
| 34 |
LUNG INFECTION PSEUDOMONAL |
1 |
0.0018 |
| 35 |
HEAD BANGING |
1 |
0.0018 |
| 36 |
GASTROINTESTINAL BACTERIAL OVERGROWTH |
1 |
0.0017 |
| 37 |
PLASMA CELL LEUKAEMIA |
1 |
0.0017 |
| 38 |
INFUSION RELATED HYPERSENSITIVITY REACTION |
1 |
0.0017 |
| 39 |
FALSE NEGATIVE INVESTIGATION RESULT |
1 |
0.0014 |
| 40 |
VASCULITIS NECROTISING |
1 |
0.0014 |
| 41 |
GRAFT VERSUS HOST DISEASE IN SKIN |
3 |
0.0014 |
| 42 |
PSEUDOMEMBRANOUS COLITIS |
3 |
0.0013 |
| 43 |
ESCHERICHIA INFECTION |
11 |
0.0013 |
| 44 |
PANCREATITIS NECROTISING |
3 |
0.0013 |
| 45 |
FUNGAL SEPSIS |
1 |
0.0012 |
| 46 |
TONGUE PRURITUS |
1 |
0.0012 |
| 47 |
TRANSFUSION REACTION |
1 |
0.0011 |
| 48 |
HYPERVIGILANCE |
1 |
0.0010 |
| 49 |
HYPOFIBRINOGENAEMIA |
1 |
0.0010 |
| 50 |
ADMINISTRATION SITE EXTRAVASATION |
1 |
0.0010 |
| 51 |
KLEBSIELLA SEPSIS |
1 |
0.0009 |
| 52 |
LABILE BLOOD PRESSURE |
1 |
0.0008 |
| 53 |
BLOOD UREA DECREASED |
1 |
0.0008 |
| 54 |
STENOTROPHOMONAS INFECTION |
1 |
0.0007 |
| 55 |
PULMONARY SEPSIS |
1 |
0.0007 |
| 56 |
CYTOMEGALOVIRUS VIRAEMIA |
3 |
0.0007 |
| 57 |
GASTROSTOMY |
1 |
0.0006 |
| 58 |
PSEUDOMONAL SEPSIS |
1 |
0.0006 |
| 59 |
BODY TEMPERATURE ABNORMAL |
1 |
0.0005 |
| 60 |
NEUTROPHILIA |
3 |
0.0005 |
| 61 |
TREATMENT FAILURE |
43 |
0.0005 |
| 62 |
INFUSION SITE EXTRAVASATION |
3 |
0.0005 |
| 63 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
2 |
0.0005 |
| 64 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
1 |
0.0004 |
| 65 |
TRANSPLANT |
1 |
0.0004 |
| 66 |
STARING |
1 |
0.0004 |
| 67 |
MUCOUS STOOLS |
2 |
0.0004 |
| 68 |
ORGANISING PNEUMONIA |
2 |
0.0004 |
| 69 |
STEM CELL TRANSPLANT |
1 |
0.0004 |
| 70 |
GASTROINTESTINAL MOTILITY DISORDER |
2 |
0.0004 |
| 71 |
GASTROINTESTINAL INJURY |
1 |
0.0004 |
| 72 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
8 |
0.0004 |
| 73 |
SYMPTOM RECURRENCE |
2 |
0.0003 |
| 74 |
EMERGENCY CARE |
1 |
0.0003 |
| 75 |
PRODUCT PRESCRIBING ISSUE |
7 |
0.0003 |
| 76 |
PANCREATITIS ACUTE |
7 |
0.0003 |
| 77 |
LIVER TRANSPLANT |
1 |
0.0003 |
| 78 |
COLITIS ULCERATIVE |
12 |
0.0003 |
| 79 |
TONGUE OEDEMA |
1 |
0.0003 |
| 80 |
BOWEL MOVEMENT IRREGULARITY |
2 |
0.0003 |
| 81 |
LEG AMPUTATION |
1 |
0.0002 |
| 82 |
HALLUCINATIONS, MIXED |
1 |
0.0002 |
| 83 |
LIP OEDEMA |
1 |
0.0002 |
| 84 |
AORTIC VALVE INCOMPETENCE |
1 |
0.0002 |
| 85 |
ILEUS PARALYTIC |
1 |
0.0002 |
| 86 |
HEPATOCELLULAR INJURY |
3 |
0.0002 |
| 87 |
CARDIAC TAMPONADE |
1 |
0.0002 |
| 88 |
STAPHYLOCOCCAL SEPSIS |
1 |
0.0002 |
| 89 |
CEREBRAL ISCHAEMIA |
1 |
0.0002 |
| 90 |
TONSILLITIS |
1 |
0.0002 |
| 91 |
TIC |
1 |
0.0002 |
| 92 |
COLECTOMY |
1 |
0.0002 |
| 93 |
ENTEROCOLITIS |
1 |
0.0002 |
| 94 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
0.0002 |
| 95 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
0.0002 |
| 96 |
PNEUMONIA ASPIRATION |
4 |
0.0002 |
| 97 |
EPSTEIN-BARR VIRUS INFECTION |
1 |
0.0002 |
| 98 |
HYPOGAMMAGLOBULINAEMIA |
1 |
0.0002 |
| 99 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 100 |
DISSEMINATED INTRAVASCULAR COAGULATION |
2 |
0.0001 |
| 101 |
PRODUCT SUPPLY ISSUE |
1 |
0.0001 |
| 102 |
ORAL DISORDER |
1 |
0.0001 |
| 103 |
PRODUCT AVAILABILITY ISSUE |
3 |
0.0001 |
| 104 |
BRONCHOPULMONARY ASPERGILLOSIS |
1 |
0.0001 |
| 105 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 106 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 107 |
ATRIAL FLUTTER |
1 |
0.0001 |
| 108 |
FRUSTRATION TOLERANCE DECREASED |
1 |
0.0001 |
| 109 |
LIVER INJURY |
3 |
0.0001 |
| 110 |
CYTOMEGALOVIRUS INFECTION |
2 |
0.0001 |
| 111 |
VITAMIN D DECREASED |
1 |
0.0001 |
| 112 |
CARDIAC FAILURE |
9 |
0.0001 |
| 113 |
ADVERSE EVENT |
10 |
0.0001 |
| 114 |
CONJUNCTIVITIS |
2 |
0.0001 |
| 115 |
DIARRHOEA HAEMORRHAGIC |
1 |
0.0001 |
| 116 |
LEUKAEMIA |
1 |
0.0001 |
| 117 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
3 |
0.0001 |
| 118 |
HYPOCALCAEMIA |
2 |
0.0001 |
| 119 |
COLITIS |
4 |
0.0001 |
| 120 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
5 |
0.0001 |
| 121 |
CARDIO-RESPIRATORY ARREST |
4 |
0.0001 |
| 122 |
INCONTINENCE |
1 |
0.0001 |
| 123 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 124 |
SEPTIC SHOCK |
4 |
0.0001 |
| 125 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
5 |
0.0001 |
| 126 |
GASTROINTESTINAL PAIN |
1 |
0.0001 |
| 127 |
MALNUTRITION |
1 |
0.0001 |
| 128 |
MYOCARDIAL ISCHAEMIA |
1 |
0.0001 |
| 129 |
CHOLECYSTECTOMY |
1 |
0.0001 |
| 130 |
PERICARDIAL EFFUSION |
2 |
0.0001 |
| 131 |
RESPIRATORY FAILURE |
6 |
0.0001 |
| 132 |
MUSCLE SPASTICITY |
1 |
0.0001 |
| 133 |
ILEUS |
1 |
0.0001 |
| 134 |
GENERAL PHYSICAL HEALTH DETERIORATION |
9 |
0.0001 |
| 135 |
INFLAMMATION |
4 |
0.0001 |
| 136 |
BEDRIDDEN |
1 |
0.0001 |
| 137 |
INFUSION RELATED REACTION |
5 |
0.0001 |
| 138 |
RESPIRATORY DISTRESS |
2 |
0.0001 |
| 139 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 140 |
THERAPY NON-RESPONDER |
3 |
0.0001 |
| 141 |
HEPATIC FAILURE |
2 |
0.0001 |
| 142 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 143 |
LYMPHOMA |
1 |
0.0001 |
| 144 |
URINARY TRACT INFECTION |
11 |
0.0001 |
| 145 |
ARTHRITIS |
5 |
0.0001 |
| 146 |
FEBRILE NEUTROPENIA |
4 |
0.0001 |
| 147 |
COAGULOPATHY |
1 |
0.0001 |
| 148 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 149 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
2 |
0.0001 |
| 150 |
THERAPY CESSATION |
3 |
0.0001 |
| 151 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 152 |
GASTRIC DISORDER |
2 |
0.0001 |
| 153 |
NEUROTOXICITY |
1 |
0.0001 |
| 154 |
PRODUCT USE IN UNAPPROVED INDICATION |
14 |
0.0001 |
| 155 |
DRUG INEFFECTIVE |
72 |
0.0001 |
| 156 |
HEPATIC FUNCTION ABNORMAL |
2 |
0.0001 |
| 157 |
DRUG PRESCRIBING ERROR |
1 |
0.0001 |
| 158 |
PYREXIA |
18 |
0.0001 |
| 159 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 160 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 161 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 162 |
ILL-DEFINED DISORDER |
3 |
0.0000 |
| 163 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 164 |
EATING DISORDER |
1 |
0.0000 |
| 165 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 166 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 167 |
DIARRHOEA |
29 |
0.0000 |
| 168 |
THROMBOCYTOPENIA |
5 |
0.0000 |
| 169 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 170 |
DISEASE RECURRENCE |
2 |
0.0000 |
| 171 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 172 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 173 |
CHRONIC KIDNEY DISEASE |
3 |
0.0000 |
| 174 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
1 |
0.0000 |
| 175 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 176 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 177 |
PALLOR |
1 |
0.0000 |
| 178 |
MOOD ALTERED |
1 |
0.0000 |
| 179 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 180 |
HAEMOPTYSIS |
1 |
0.0000 |
| 181 |
FLATULENCE |
2 |
0.0000 |
| 182 |
PAIN IN EXTREMITY |
10 |
0.0000 |
| 183 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 184 |
APHASIA |
1 |
0.0000 |
| 185 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 186 |
PLEURAL EFFUSION |
2 |
0.0000 |
| 187 |
EPILEPSY |
1 |
0.0000 |
| 188 |
PRODUCT USE ISSUE |
6 |
0.0000 |
| 189 |
PULMONARY EMBOLISM |
3 |
0.0000 |
| 190 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 191 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 192 |
DELIRIUM |
1 |
0.0000 |
| 193 |
ABDOMINAL DISTENSION |
3 |
0.0000 |
| 194 |
RASH MACULAR |
1 |
0.0000 |
| 195 |
HYPOXIA |
1 |
0.0000 |
| 196 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 197 |
VOMITING |
13 |
0.0000 |
| 198 |
NO ADVERSE EVENT |
5 |
0.0000 |
| 199 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 200 |
PANIC ATTACK |
1 |
0.0000 |
| 201 |
UNDERDOSE |
2 |
0.0000 |
| 202 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 203 |
ABORTION SPONTANEOUS |
1 |
0.0000 |
| 204 |
HYPOTENSION |
5 |
0.0000 |
| 205 |
URTICARIA |
4 |
0.0000 |
| 206 |
ABDOMINAL DISCOMFORT |
4 |
0.0000 |
| 207 |
RENAL IMPAIRMENT |
2 |
0.0000 |
| 208 |
ANGIOEDEMA |
1 |
0.0000 |
| 209 |
NEUTROPENIA |
3 |
0.0000 |
| 210 |
DEATH |
19 |
0.0000 |
| 211 |
HYPOKALAEMIA |
1 |
0.0000 |
| 212 |
NAUSEA |
17 |
0.0000 |
| 213 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 214 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 215 |
ARRHYTHMIA |
1 |
0.0000 |
| 216 |
INFECTION |
3 |
0.0000 |
| 217 |
DRUG INTOLERANCE |
2 |
0.0000 |
| 218 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 219 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 220 |
LEUKOPENIA |
1 |
0.0000 |
| 221 |
MALIGNANT NEOPLASM PROGRESSION |
2 |
0.0000 |
| 222 |
NERVOUSNESS |
1 |
0.0000 |
| 223 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 224 |
PNEUMONIA |
6 |
0.0000 |
| 225 |
OEDEMA |
1 |
0.0000 |
| 226 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 227 |
NECK PAIN |
1 |
0.0000 |
| 228 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 229 |
SEIZURE |
2 |
0.0000 |
| 230 |
PALPITATIONS |
2 |
0.0000 |
| 231 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 232 |
FEELING HOT |
1 |
0.0000 |
| 233 |
CHEST PAIN |
3 |
0.0000 |
| 234 |
ANAEMIA |
3 |
0.0000 |
| 235 |
SWELLING FACE |
1 |
0.0000 |
| 236 |
RENAL FAILURE |
2 |
0.0000 |
| 237 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 238 |
HYPERTENSION |
3 |
0.0000 |
| 239 |
DYSPNOEA |
8 |
0.0000 |
| 240 |
OVERDOSE |
3 |
0.0000 |
| 241 |
PRURITUS |
5 |
0.0000 |
| 242 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 243 |
RASH |
5 |
0.0000 |
| 244 |
OFF LABEL USE |
10 |
0.0000 |
| 245 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 246 |
TACHYCARDIA |
1 |
0.0000 |
| 247 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 248 |
HEADACHE |
7 |
0.0000 |
| 249 |
COUGH |
3 |
0.0000 |
| 250 |
DYSPHAGIA |
1 |
0.0000 |
| 251 |
PRODUCT DOSE OMISSION ISSUE |
3 |
0.0000 |
| 252 |
FLUSHING |
1 |
0.0000 |
| 253 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 254 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 255 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 256 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 257 |
MALAISE |
4 |
0.0000 |
| 258 |
SEPSIS |
1 |
0.0000 |
| 259 |
INCORRECT DOSE ADMINISTERED |
2 |
0.0000 |
| 260 |
DECREASED APPETITE |
2 |
0.0000 |
| 261 |
CHILLS |
1 |
0.0000 |
| 262 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 263 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 264 |
PAIN |
5 |
0.0000 |
| 265 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 266 |
ASTHENIA |
3 |
0.0000 |
| 267 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 268 |
PARAESTHESIA |
1 |
0.0000 |
| 269 |
DRUG INTERACTION |
1 |
0.0000 |
| 270 |
TREMOR |
1 |
0.0000 |
| 271 |
DIZZINESS |
3 |
0.0000 |
| 272 |
COVID-19 |
1 |
0.0000 |
| 273 |
ALOPECIA |
1 |
0.0000 |
| 274 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 275 |
ERYTHEMA |
1 |
0.0000 |
| 276 |
CONSTIPATION |
1 |
0.0000 |
| 277 |
WEIGHT INCREASED |
1 |
0.0000 |
| 278 |
BACK PAIN |
1 |
0.0000 |
| 279 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 280 |
FEELING ABNORMAL |
1 |
0.0000 |
| 281 |
INSOMNIA |
1 |
0.0000 |
| 282 |
WEIGHT DECREASED |
1 |
0.0000 |
| 283 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 284 |
FATIGUE |
2 |
0.0000 |
| 285 |
ARTHRALGIA |
1 |
0.0000 |